Why Abemaciclib in HR+/HER2- MBC patients?

Dear Dr. Renukaprasad A R, Do you know that abemaciclib has a potential role in MBC patients with liver metastasis and poor prognosis? Abemaciclib is found to have significant benefits in treating hormone receptor-positive (HR+) or human epidermal growth receptor-2 negative (HER2-) metastatic breast cancer (MBC) patients, as it can also address factors like liver metastasis and poor prognosis. Join us for this exclusive webinar on 19th September 2022 at 07:30 PM IST with our renowned experts as they share their perspectives on what influenced them to choose Ramiven� for treating HR+/ HER2- MBC patients and how they tailor the treatment. Session highlights: Abemaciclib as a first-line therapy - Dr. Anwar Al Nouri Clinical case presentation I - Dr. Anwar Al Nouri Clinical case presentation II - Dr. J. B. Sharma Clinical case presentation III - Dr. Sushant Mittel Clinical case presentation IV - Dr. Samit Purohit Q&A with the experts: Tailoring treatment in HR+/HER2- MBC based on prognostic factors Click to Know More   Save the Date India's Largest Online Community of Verified Doctors Pune - 411045, India info@docplexus.co.in�� |� +91 98500 36954 You are receiving this communication because you are registered member of Docplexus. Unsubscribe from this mailing list. *|LIST:DESCRIPTION|* *|LIST:ADDRESS|* *|REWARDS_TEXT|*